Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dev Center BiotechnologyfiledCriticalDev Center Biotechnology
Priority to TW81105934ApriorityCriticalpatent/TW288047B/zh
Application grantedgrantedCritical
Publication of TW288047BpublicationCriticalpatent/TW288047B/zh
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
TW81105934A1992-07-281992-07-28Method for producing the replication activator (ZEBRA) of Taiwan strain epstein-barr virus as antigen protein
TW288047B
(en)
Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid
The role of herpes simplex virus ribonucleotide reductase small subunit carboxyl terminus in subunit interaction and formation of iron-tyrosyl center structure.
Induction by chemically modified actin derivatives of antibody specificity: A relation between modified sites and antibody interactions with monomeric and filamentous actins